All News
Filter News
Found 124 articles
-
Kowa Research Institute, Inc. Release: Landmark Trial Entitled "PROMINENT" To Explore The Prevention Of Heart Disease In Diabetic Patients With High Triglycerides And Low HDL-C
1/12/2016
-
Cipher Pharma Reports Third Quarter Results
11/4/2015
-
Cipher Pharma Reports Financial And Operational Results For Q1 2015
5/13/2015
-
Kowa Pharmaceuticals America Release: New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease
5/4/2015
-
Sirona Biochem To Present At BioNetwork East - May 2015
4/13/2015
-
Kowa Pharmaceuticals America Release: Landmark Trial To Explore The Prevention Of Heart Disease In People Living With HIV
10/28/2014
-
Kowa Pharmaceuticals America Release: Data Showed After 52 Weeks, LIVALO® (Pitavastatin) 4 Mg Maintained Similar Safety And Significantly Greater LDL-C Reduction Compared With Pravastatin 40 Mg In HIV-Infected Adults With Dyslipidemia
5/1/2014
-
Amarin Corporation PLC And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules
4/1/2014
-
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
6/17/2013
-
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg
3/7/2013
-
Gentronix Limited Signs First Japanese Contracted Screening Collaboration With Kowa Company
9/5/2012
-
Kowa Pharmaceuticals America, Eli Lilly and Company Release Results From a Pharmacokinetic Study
7/23/2012
-
John O'Hurley Teams Up With the National Lipid Association, Kowa Pharmaceuticals America and Eli Lilly and Company to Announce Results of Landmark Statin USAGE Survey, Largest Known Survey of Cholesterol Patients
6/19/2012
-
Eli Lilly and Company and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study
5/31/2012
-
Kowa Pharmaceuticals America Release: New Study Data Published Assessing the Effect of LIVALO(R) vs. Crestor(R) on International Normalized Ratio on Steady-State Warfarin
2/13/2012
-
Kowa Company Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in American Heart Association 2011
11/10/2011
-
Teva Pharmaceutical Industries Limited Buys Rest of Japanese JV for $150 Million
9/26/2011
-
Kowa Pharmaceuticals America Release: New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
7/18/2011
-
Cipher Pharmaceuticals And Vertical Pharmaceuticals Complete U.S. Distribution And Supply Agreement For Extended-Release Tramadol
6/29/2011
-
Cipher Pharmaceuticals Acne Drug Shows Comparable Safety, Efficacy
6/7/2011